Skip to main content

Part of the book series: La « Collection SNFCP » ((SNFCP))

  • 372 Accesses

Résumé

La diarrhée est un facteur aggravant de l’incontinence anale [1–3]. En cas de diarrhée, le premier objectif du traitement médical doit être de traiter ce trouble du transit. L’importance de la correction des troubles du transit chez les malades incontinents est suggérée par le fait que le traitement médical orienté par la mesure du temps de transit colique est le plus souvent efficace [4] (niveau 3); c’est plus la viscosité du contenu rectal que la présence d’éventuels éléments irritants (orlistat, acides gras, graisse) qui explique les difficultés de continence chez les patients ayant des troubles de la fonction anorectale [5].

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Références

  1. Bharucha AE, Zinsmeister AR, Schleck CD, Melton LJ, 3rd (2010) Bowel disturbances are the most important risk factors for late onset fecal incontinence: a population-based case-control study in women. Gastroenterology 139(5): 1559–66. Epub 2010/08/17

    Article  PubMed  Google Scholar 

  2. Rey E, Choung RS, Schleck CD, et al. (2010) Onset and risk factors for fecal incontinence in a US community. Am J Gastroenterol 105(2): 412–9. Epub 2009/10/22

    Article  PubMed  Google Scholar 

  3. Whitehead WE, Borrud L, Goode PS, et al. (2009) Fecal Incontinence in US. Adults: Epidemiology and Risk Factors. Gastroenterology 137(2): 512–7

    Article  PubMed  Google Scholar 

  4. Bouchoucha M, Devroede G, Faye A, Arsac M (2002) Importance of colonic transit evaluation in the management of fecal incontinence. Int J Colorectal Dis 17(6): 412–7; discussion 8–9

    Article  PubMed  Google Scholar 

  5. Fox M, Schwizer W, Menne D, et al. (2004) The physical properties of rectal contents have effects on anorectal continence: insights from a study into the cause of fecal spotting on orlistat. Dis Colon Rectum 47(12): 2147–56

    Article  PubMed  Google Scholar 

  6. Sandhu BK, Tripp JH, Candy DC, Harries JT (1981) Loperamide: studies on its mechanism of action. Gut 22(8): 658–62. Epub 1981/08/01

    Article  CAS  PubMed  Google Scholar 

  7. Schiller LR, Santa Ana CA, Morawski SG, Fordtran JS (1984) Mechanism of the antidiarrheal effect of loperamide. Gastroenterology 86(6): 1475–80. Epub 1984/06/01

    CAS  PubMed  Google Scholar 

  8. Van Nueten JM, Janssen PA, Fontaine J (1974) Loperamide (R 18 553), a novel type of antidiarrheal agent. Part 3: in vitro studies on the peristaltic reflex and other experiments on isolated tissues. Arzneimittelforschung 24(10): 1641–5. Epub 1974/10/01

    PubMed  Google Scholar 

  9. Tytgat GN, Huibregtse K (1975) Loperamide and ileostomy output—-placebo-controled double-blind crossover study. Br Med J 2(5972): 667. Epub 1975/06/21

    Article  CAS  PubMed  Google Scholar 

  10. Kachel G, Ruppin H, Hagel J, et al. (1986) Human intestinal motor activity and transport: effects of a synthetic opiate. Gastroenterology 90(1): 85–93. Epub 1986/01/01

    CAS  PubMed  Google Scholar 

  11. Rattan S, Culver PJ (1987) Influence of loperamide on the internal anal sphincter in the opossum. Gastroenterology 93(1): 121–8. Epub 1987/07/01

    CAS  PubMed  Google Scholar 

  12. Musial F, Enck P, Kalveram KT, Erckenbrecht JF (1992) The effect of loperamide on anorectal function in normal healthy men. J Clin Gastroenterol 15(4): 321–4

    Article  CAS  PubMed  Google Scholar 

  13. Emblem R, Stien R, Morkrid L (1989) The effect of loperamide on bowel habits and anal sphincter function in patients with ileoanal anastomosis. Scand J Gastroenterol 24(8): 1019–24

    Article  CAS  PubMed  Google Scholar 

  14. Hallgren T, Fasth S, Delbro DS, et al. (1994) Loperamide improves anal sphincter function and continence after restorative proctocolectomy. Dig Dis Sci 39(12): 2612–8

    Article  CAS  PubMed  Google Scholar 

  15. Read M, Read NW, Barber DC, Duthie HL (1982) Effects of loperamide on anal sphincter function in patients complaining of chronic diarrhea with fecal incontinence and urgency. Dig Dis Sci 27(9): 807–14

    Article  CAS  PubMed  Google Scholar 

  16. Harford WV, Krejs GJ, Santa Ana CA, Fordtran JS (1980) Acute effect of diphenoxylate with atropine (Lomotil) in patients with chronic diarrhea and fecal incontinence. Gastroenterology 78(3): 440–3. Epub 1980/03/01

    CAS  PubMed  Google Scholar 

  17. Read MG, Read NW, Haynes WG, et al. (1982) A prospective study of the effect of haemorrhoidectomy on sphincter function and faecal continence. Br J Surg 69(7): 396–8

    Article  CAS  PubMed  Google Scholar 

  18. Palmer KR, Corbett CL, Holdsworth CD (1980) Double-blind cross-over study comparing loperamide, codeine and diphenoxylate in the treatment of chronic diarrhea. Gastroenterology. 79(6): 1272–5. Epub 1980/12/01

    CAS  PubMed  Google Scholar 

  19. Sun WM, Read NW, Verlinden M (1997) Effects of loperamide oxide on gastrointestinal transit time and anorectal function in patients with chronic diarrhoea and faecal incontinence. Scandinavian Journal of Gastroenterology 32(1): 34–8. Epub 1997/01/01

    Article  CAS  PubMed  Google Scholar 

  20. Fox M, Stutz B, Menne D, et al. (2005) The effects of loperamide on continence problems and anorectal function in obese subjects taking orlistat. Dig Dis Sci 50(9): 1576–83. Epub 2005/09/01

    Article  CAS  PubMed  Google Scholar 

  21. Lauti M, Scott D, Thompson-Fawcett MW (2008) Fibre supplementation in addition to loperamide for faecal incontinence in adults: a randomized trial. Colorectal Dis 10(6): 553–62. Epub 2008/01/15

    Article  CAS  PubMed  Google Scholar 

  22. Sze EH, Hobbs G (2009) Efficacy of methylcellulose and loperamide in managing fecal incontinence. Acta Obstet Gynecol Scand 88(7): 766–71. Epub 2009/05/20

    Article  CAS  PubMed  Google Scholar 

  23. Cohen LD, Levitt MD (2001) A comparison of the effect of loperamide in oral or suppository form vs placebo in patients with ileo-anal pouches. Colorectal Dis 3(2): 95–9. Epub 2003/06/07

    Article  CAS  PubMed  Google Scholar 

  24. Regadas FS, Batista LK, Albuquerque JL, Capaz FR (1993) Pharmacological study of the internal and sphincter in patients with chronic anal fissure. Br J Surg 80(6): 799–801. Epub 1993/06/01

    Article  CAS  PubMed  Google Scholar 

  25. O’Kelly TJ, Brading A, Mortensen NJ (1993) In vitro response of the human anal canal longitudinal muscle layer to cholinergic and adrenergic stimulation: evidence of sphincter specialization. Br J Surg 80(10): 1337–41. Epub 1993/10/01

    Article  CAS  Google Scholar 

  26. Yamato S, Rattan S (1990) Role of alpha adrenoceptors in opossum internal anal sphincter. J Clin Invest 86(2): 424–9. Epub 1990/08/01

    Article  CAS  PubMed  Google Scholar 

  27. Carapeti EA, Kamm MA, Phillips RK (2000) Randomized controlled trial of topical phenylephrine in the treatment of faecal incontinence. Br J Surg 87(1): 38–42

    Article  CAS  PubMed  Google Scholar 

  28. Cheetham MJ, Kamm MA, Phillips RK (2001) Topical phenylephrine increases anal canal resting pressure in patients with faecal incontinence. Gut 48(3): 356–9

    Article  CAS  PubMed  Google Scholar 

  29. Park JS, Kang SB, Kim DW, et al. (2007) The efficacy and adverse effects of topical phenylephrine for anal incontinence after low anterior resection in patients with rectal cancer. Int J Colorectal Dis 22(11): 1319–24

    Article  PubMed  Google Scholar 

  30. Badvie S, Andreyev HJ (2005) Topical phenylephrine in the treatment of radiation-induced faecal incontinence. Clinical oncology (Royal College of Radiologists (Great Britain)) 17(2):122–6. Epub 2005/04/16

    Article  CAS  Google Scholar 

  31. Himpens B, Missiaen L, Droogmans G, Casteels R (1991) AlF4-induces Ca2+ oscillations in guinea-pig ileal smooth muscle. Pflugers Archiv 417(6):645–50

    Article  CAS  PubMed  Google Scholar 

  32. Nasu T, Suzuki N (1998) Effects of aluminum ions on K(+)-induced contraction in ileal longitudinal smooth muscle. Comparative biochemistry and physiology Part C, Pharmacology, toxicology & endocrinology 120(1): 137–43. Epub 1998/11/25

    CAS  Google Scholar 

  33. Pinedo G, Zarate AJ, Inostroza G, et al (2012) New treatment for faecal incontinence using zinc-aluminium ointment: a double-blind randomized trial. Colorectal Dis 14(5): 596–8. Epub 2011/07/26

    Article  CAS  PubMed  Google Scholar 

  34. Shoji Y, Kusunoki M, Yanagi H, et al (1993) Effects of sodium valproate on various intestinal motor functions after ileal J pouch-anal anastomosis. Surgery 113(5): 560–3

    CAS  PubMed  Google Scholar 

  35. Maeda K, Maruta M, Sato H, et al (2002) Effect of oral diazepam on anal continence after low anterior resection: a preliminary study. Tech Coloproctol 6(1): 15–8

    Article  CAS  PubMed  Google Scholar 

  36. Santoro GA, Eitan BZ, Pryde A, Bartolo DC (2000) Open study of low-dose amitriptyline in the treatment of patients with idiopathic fecal incontinence. Dis Colon Rectum 43(12): 1676–81; discussion 81–2

    Article  CAS  PubMed  Google Scholar 

  37. Remes-Troche JM, Ozturk R, Philips C, et al (2008) Cholestyramine—-a useful adjunct for the treatment of patients with fecal incontinence. Int J Colorectal Dis 23(2): 189–94

    Article  PubMed  Google Scholar 

  38. Franz HB, Wendler D, Oettling G (1996) Immunohistochemical assessment of steroid hormone receptors in tissues of the anal canal. Implications for anal incontinence? Acta Obstet Gynecol Scand75(10): 892–5

    Article  CAS  PubMed  Google Scholar 

  39. Haadem K, Ling L, Ferno M, Graffner H (1991) Estrogen receptors in the external anal sphincter. Am J Obstet Gynecol 164(2): 609–10. Epub 1991/02/01

    Article  CAS  PubMed  Google Scholar 

  40. Eogan M, O’Brien C, Daly L, et al (2011) The dual influences of age and obstetric history on fecal continence in parous women. Int J Gynaecol Obstet 112(2): 93–7. Epub 2010/11/17

    Article  PubMed  Google Scholar 

  41. Kepenekci I, Keskinkilic B, Akinsu F, et al (2011) Prevalence of pelvic floor disorders in the female population and the impact of age, mode of delivery, and parity. Dis Colon Rectum 54(1): 85–94. Epub 2010/12/17

    Article  PubMed  Google Scholar 

  42. Rizk DE, Hassan HA, Al-Marzouqi AH, et al (2008) Combined estrogen and ghrelin administration decreases expression of p27(kip1) and proportion of isomyosin type I in the striated urethral and anal sphincters and levator ani of old ovariectomized rats. Int Urogynecol J Pelvic Floor Dysfunct 19(10): 1363–9. Epub 2008/05/23

    Article  PubMed  Google Scholar 

  43. Donnelly V, O’Connell PR, O’Herlihy C (1997) The influence of oestrogen replacement on faecal incontinence in postmenopausal women [see comments]. British journal of obstetrics and gynaecology 104(3): 311–5

    Article  CAS  PubMed  Google Scholar 

  44. Pinedo G, Garcia E, Zarate AJ, et al (2009) Are topical oestrogens useful in faecal incontinence? Double-blind randomized trial. Colorectal Dis 11(4): 390–3. Epub 2008/07/19

    Article  CAS  PubMed  Google Scholar 

  45. MacLennan AH (2007) HRT: a reappraisal of the risks and benefits. Med J Aust 186(12): 643–6. Epub 2007/06/20

    PubMed  Google Scholar 

  46. Cheetham Mark J, Brazzelli M, North C, Glazener Cathryn MA (2003) Drug treatment for feacal incontinence in adults. Cochrane Database of Systematic Reviews

    Google Scholar 

  47. Bliss DZ, Savik K, Jung HJ, et al (2011) Symptoms associated with dietary fiber supplementation over time in individuals with fecal incontinence. Nurs Res 60(3 Suppl): S58–67. Epub 2011/05/14

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to F. Pigot .

Rights and permissions

Reprints and permissions

Copyright information

© 2013 Springer-Verlag Paris

About this chapter

Cite this chapter

Pigot, F. (2013). Traitement médical. In: Incontinence anale de l’adulte. La « Collection SNFCP ». Springer, Paris. https://doi.org/10.1007/978-2-8178-0456-9_5

Download citation

  • DOI: https://doi.org/10.1007/978-2-8178-0456-9_5

  • Publisher Name: Springer, Paris

  • Print ISBN: 978-2-8178-0455-2

  • Online ISBN: 978-2-8178-0456-9

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics